|
ZDHHC7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.174900E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.602400E-03 |
| Normal-vs-Stage2 |
3.878100E-02 |
| Normal-vs-Stage3 |
1.13390000000546E-06 |
| Normal-vs-Stage4 |
1.842690E-03 |
| Stage1-vs-Stage2 |
6.994200E-01 |
| Stage1-vs-Stage3 |
1.235350E-03 |
| Stage1-vs-Stage4 |
1.822370E-01 |
| Stage2-vs-Stage3 |
2.118000E-01 |
| Stage2-vs-Stage4 |
6.133800E-01 |
| Stage3-vs-Stage4 |
3.550400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.32889999999864E-05 |
| Normal-vs-AfricanAmerican |
1.886560E-01 |
| Normal-vs-Asian |
7.841000E-01 |
| Caucasian-vs-AfricanAmerican |
7.584400E-02 |
| Caucasian-vs-Asian |
9.283800E-02 |
| AfricanAmerican-vs-Asian |
1.747560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.569200E-04 |
| Normal-vs-Female |
1.761610E-03 |
| Male-vs-Female |
6.314600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.568000E-02 |
| Normal-vs-Age(41-60Yrs) |
4.501700E-03 |
| Normal-vs-Age(61-80Yrs) |
2.417300E-04 |
| Normal-vs-Age(81-100Yrs) |
2.462200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.711200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.530600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.097200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.650360E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.056430E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.191600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.036600E-01 |
| Normal-vs-Grade 2 |
1.902840E-03 |
| Normal-vs-Grade 3 |
1.218100E-04 |
| Normal-vs-Grade 4 |
2.543400E-03 |
| Grade 1-vs-Grade 2 |
1.975220E-01 |
| Grade 1-vs-Grade 3 |
9.119600E-02 |
| Grade 1-vs-Grade 4 |
1.366430E-01 |
| Grade 2-vs-Grade 3 |
4.399200E-01 |
| Grade 2-vs-Grade 4 |
6.372200E-01 |
| Grade 3-vs-Grade 4 |
9.420400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.15039999537947E-08 |
| Normal-vs-ccB subtype |
9.415800E-02 |
| ccA subtype-vs-ccB subtype |
1.841920E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.985600E-04 |
| Normal-vs-N1 |
8.244600E-01 |
| N0-vs-N1 |
1.302960E-01 |
|
|
